TrialHaemophilia : the official journal of the World Federation of Hemophilia2022

Effect of emicizumab prophylaxis on bone and joint health markers in people with haemophilia A without factor VIII inhibitors in the HAVEN 3 study.

Anna Kiialainen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.